A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 55 X posts from 29 X users, with an upper bound of 143,911 followers.

RT @AndyBiotech: First patient achieved complete remission in tandem CD19/CD20 CAR-T trial using @miltenyibiotec CliniMACS Prodigy system h…

RT @AndyBiotech: First patient achieved complete remission in tandem CD19/CD20 CAR-T trial using @miltenyibiotec CliniMACS Prodigy system h…

RT @AndyBiotech: First patient achieved complete remission in tandem CD19/CD20 CAR-T trial using @miltenyibiotec CliniMACS Prodigy system h…

RT @AndyBiotech: First patient achieved complete remission in tandem CD19/CD20 CAR-T trial using @miltenyibiotec CliniMACS Prodigy system h…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 51 additional X posts.